They should continue to be seen as [a] fundamental overweight on anything longer than a one-month horizon,' the bank said.

The size of Elliott's stake in Glaxo wasn't disclosed. Elliott is headed by iconic investor Paul Singer. Glaxo's shares rose.

German drugmaker CureVac will team with pharma giant GlaxoSmithKline to develop a new m-RNA coronavirus vaccine candidate.

CureVac says its covid vaccine candidate provided full protection of the lungs in animal testing.

CureVac, a German biotech listed on the Nasdaq, will accelerate the development of its coronavirus vaccine with pharma giant Bayer AG.

Bayer will make a total payment of $10.1 billion to $10.9 billion to settle the claims that Roundup caused cancer.

A federal appeals court rejects the EPA's permit to sell Bayer's dicamba-based XtendiMax.

Stock futures rise but gains are capped by lingering concerns over the spread of the coronavirus in China; Intel smashes earnings estimates and sees robust sales in 2020; Broadcom sees $15 billion in revenue from deals with Apple; Jamie Dimon's pay in 2019 rises to $31.5 million.

Bayer, which markets the weedkiller Roundup, is in talks to create what might become a $10 billion settlement of tens of thousands of cancer lawsuits.

Tesla's billionaire CEO is calling on the Biden administration to make a move against the mass incarceration of people for weed.

Stocks finished the day mixed as investors reappraised inflation concerns and the potential impact on interest rates.

Royal Caribbean cruise line has slowly returned to its prepandemic normal, and Carnival Cruise is likely to follow on soon.